Castle Biosciences, Inc. (CSTL) vs OPKO Health, Inc. (OPK)
- Castle Biosciences, Inc. CSTL 31.96 −5.44%
- OPKO Health, Inc. OPK 1.53 −4.97%
Castle Biosciences, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. OPKO Health, Inc. is the larger, with a market value of $1.2B against $1.0B — 1.2× the size. Castle Biosciences, Inc. grew revenue faster over the last twelve months: 3.18% against −11.5%. Castle Biosciences, Inc. has the higher net margin (−5.43% vs −12.4%) and the lower return on invested capital (−9.40% vs −2.45%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 13 and OPKO Health, Inc. on 5.
Valuation
Profitability
| Metric | CSTL | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.26% | 40.77% | 50.89% |
| Operating margin | (8.99%) | (8.21%) | (8.57%) |
| Net margin | (5.43%) | (12.40%) | (6.37%) |
| Free cash flow margin | (0.13%) | (22.75%) | 0.00% |
| Return on equity | (4.20%) | (5.88%) | (2.92%) |
| Return on assets | (3.51%) | (3.83%) | (6.71%) |
| Return on invested capital | (9.40%) | (2.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack